Disclosure
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Ltd) has informed the BSE that the trading window for its insiders will be closed from Tuesday, July 1, 2025, until 48 hours after the unaudited financial results for the quarter ending June 30, 2025 (Q1 FY26) are made public. The closure covers all directors, promoters, key managerial personnel, designated persons, employees, and their immediate relatives, as required under SEBI insider trading rules. The company will separately inform the stock exchange about the date of the board meeting to approve the Q1 results. BSE Scrip Code is 531686 and ASE Scrip Code is 01636 (ADVIK LABO).
This is a routine compliance filing with no direct impact on the share price. It indicates that Q1 FY26 results are due soon, which could act as a near-term trigger for stock movement once announced.